These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 32982

  • 1. An application of receptor models to the analysis of data on beta-adrenoceptor blockade.
    Ferguson RA, Robertson HH, Bilski AJ, Wale JL.
    Clin Exp Pharmacol Physiol; 1979; 6(1):21-9. PubMed ID: 32982
    [Abstract] [Full Text] [Related]

  • 2. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE, Cavero I, Manoury P, Lefevre-Borg F, Langer SZ.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [Abstract] [Full Text] [Related]

  • 3. A study of the relationship between cardiac beta-adrenoceptor blockade and intrinsic sympathomimetic activity in rats depleted of catecholamines.
    Bilski A, Robertson HH, Wale JL.
    Clin Exp Pharmacol Physiol; 1979 Sep; 6(1):1-9. PubMed ID: 32980
    [Abstract] [Full Text] [Related]

  • 4. The pharmacology of epanolol (ICI 141292)--a new beta 1-selective adrenoceptor partial agonist.
    Bilski AJ, Hadfield SE, Wale JL.
    J Cardiovasc Pharmacol; 1988 Aug; 12(2):227-32. PubMed ID: 2459554
    [Abstract] [Full Text] [Related]

  • 5. Mediation of the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat by atypical beta-adrenoceptors, different from beta 3-adrenoceptors.
    Malinowska B, Schlicker E.
    Br J Pharmacol; 1996 Mar; 117(5):943-9. PubMed ID: 8851515
    [Abstract] [Full Text] [Related]

  • 6. Reduced beta-adrenoceptor sensitivity in the elderly.
    Vestal RE, Wood AJ, Shand DG.
    Clin Pharmacol Ther; 1979 Aug; 26(2):181-6. PubMed ID: 37014
    [Abstract] [Full Text] [Related]

  • 7. Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat.
    Kaumann AJ, Molenaar P.
    Br J Pharmacol; 1996 Aug; 118(8):2085-98. PubMed ID: 8864547
    [Abstract] [Full Text] [Related]

  • 8. On equilibrium dissociation constants for complexes of drug-receptor subtypes. Selective and non-selective interactions of partial agonists with two plausible beta-adrenoceptor subtypes mediating positive chronotropic effects of (-)-isoprenaline in kitten atria.
    Kaumann AJ, Marano M.
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):192-201. PubMed ID: 6121297
    [No Abstract] [Full Text] [Related]

  • 9. The beta 1- and beta 2-adrenoceptor stimulatory effects of alprenolol, oxprenolol and pindolol: a study in the isolated right atrium and uterus of the rat.
    Abrahamsson T.
    Br J Pharmacol; 1986 Apr; 87(4):657-64. PubMed ID: 2871880
    [Abstract] [Full Text] [Related]

  • 10. The lack of a pronounced preference of prenalterol for the beta-l-adrenoceptor subtype.
    Rohm N, Wagner J, Schümann HJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Apr; 315(1):85-8. PubMed ID: 6113550
    [Abstract] [Full Text] [Related]

  • 11. Beta 1- and beta 2-adrenoceptor binding and functional response in right and left atria of rat heart.
    Juberg EN, Minneman KP, Abel PW.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):193-202. PubMed ID: 2865685
    [Abstract] [Full Text] [Related]

  • 12. On the use of a dynamic approach to the estimation of dissociation constants for reversible competitive antagonists.
    Amidon GL, Buckner CK.
    J Pharmacol Exp Ther; 1981 Feb; 216(2):352-6. PubMed ID: 6257889
    [Abstract] [Full Text] [Related]

  • 13. Evidence from agonist and antagonist studies to suggest that the beta1-adrenoceptors subserving the positive inotropic and chronotropic responses of the heart do not belong to two separate subgroups.
    Lumley P, Broadley KJ.
    J Pharm Pharmacol; 1977 Oct; 29(10):598-604. PubMed ID: 21238
    [Abstract] [Full Text] [Related]

  • 14. beta 1-and beta 2-adrenoceptor stimulatory effects of prenalterol.
    Mattsson H, Andersson T, Carlsson E, Hedberg A, Lundgren B, Olsson T.
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(4):302-8. PubMed ID: 6132344
    [Abstract] [Full Text] [Related]

  • 15. Beta 1- and beta 2-adrenoceptor antagonist activities of ICI-215001, a putative beta 3-adrenoceptor agonist.
    Tesfamariam B, Allen GT.
    Br J Pharmacol; 1994 May; 112(1):55-8. PubMed ID: 7913381
    [Abstract] [Full Text] [Related]

  • 16. Beta-adrenoceptor antagonists (non-selective as well as beta 1-selective) with partial agonistic activity decrease beta 2-adrenoceptor density in human lymphocytes. Evidence for a beta 2-agonistic component of the partial agonistic activity.
    Brodde OE, Schemuth R, Brinkmann M, Wang XL, Daul A, Borchard U.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jun; 333(2):130-8. PubMed ID: 2875397
    [Abstract] [Full Text] [Related]

  • 17. (+/-)-Pindolol acts as a partial agonist at atypical beta-adrenoceptors in the guinea pig duodenum.
    Horinouchi T, Koike K.
    Jpn J Pharmacol; 2001 Jan; 85(1):35-40. PubMed ID: 11243572
    [Abstract] [Full Text] [Related]

  • 18. [Cardiac beta receptors--experimental aspects].
    Kaumann AJ.
    Z Kardiol; 1983 Feb; 72(2):63-82. PubMed ID: 6133398
    [Abstract] [Full Text] [Related]

  • 19. Comparative chronotropic activity of beta-adrenoceptive antagonists.
    Barrett AM, Carter J.
    Br J Pharmacol; 1970 Nov; 40(3):373-81. PubMed ID: 4395742
    [Abstract] [Full Text] [Related]

  • 20. Effects of in vivo beta-adrenoceptor down-regulation on cardiac responses to prenalterol and pirbuterol.
    Kenakin TP, Ferris RM.
    J Cardiovasc Pharmacol; 1983 Nov; 5(1):90-7. PubMed ID: 6186866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.